Machine learning prediction for early-stage melanoma outcomes: recurrence-free survival, disease-specific survival, and overall survival
Year: 2025
Type: preprint
Study design: Observational Study
Abstract: This study compared machine-learning models for predicting recurrence-free survival (RFS), disease-specific survival (DSS), and overall survival (OS) using clinicopathologic data from 1,621 stage I/II primary cutaneous melanoma patients. Our time-to-event models achieved concordance indices of 0.829 for RFS, 0.812 for DSS, and 0.778 for OS. Tumor thickness and mitotic rate were the most important predictors for RFS. Charlson comorbidity score and insurance type were critical for DSS and OS.
Source: medRxiv
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: RISK PREDICTION MODELS FOR RARE MELANOMAS, G6921871960, Mitigating Hematologic Adverse Events in Patients with Myeloid Malignancies: A Novel Causal Artificial Intelligence Approach, Explainable Artificial Intelligence for Melanoma Recurrence Prediction via Integrative Modeling of Multiplexed Imaging with Transcriptomics and Histopathology, Predictive modeling of cutaneous immune checkpoint inhibitor toxicities, Robust, Generalizable, and Fair Machine Learning Models for Biomedicine
OpenAlex ID: W4410851959
